Smarter Donor Selection Through HLA & Advanced Testing

Every organ donation can create a second chance at life. World Organ Donation Day is an opportunity to raise awareness about organ donation and the importance of timely, evidence-based donor selection.

Our laboratory supports transplant teams with advanced immunogenetic and antibody testing that can help assess donor–recipient compatibility and immunological risk.

Why Donor Selection Matters?

A suitable donor is not selected by blood group or clinical parameters alone. For many transplants, the recipient’s immune system must also be considered.

HLA typing, kinship analysis, Form 5 documentation, Single Antigen Bead (SAB) testing, and donor-specific antibody (DSA) assessment can provide complementary information for a structured immunological evaluation.

Final donor acceptance remains the responsibility of the treating transplant team and the applicable transplant authority.

HLA: The Foundation of Immunological Matching

Human Leukocyte Antigen (HLA) molecules help the immune system distinguish self from non-self. HLA compatibility can influence the risk of rejection and the interpretation of recipient antibodies.

Accurate HLA typing provides the foundation for donor–recipient immunological assessment and helps transplant teams interpret antibody results in context.

Kinship Analysis

When a biological relationship needs to be established, HLA-based kinship analysis can support pedigree or relationship assessment.

This can be relevant in living-donor evaluation and in situations where biological relationship documentation is required. Results should be interpreted alongside clinical records and applicable legal or regulatory requirements.

India’s transplant law — the Transplantation of Human Organs and Tissues Act (THOTA), 2014 — restricts living donation mainly to “near relatives”: parents, children, siblings, spouses, and grandparents/grandchildren. This rule exists for a good reason: to prevent commercial organ trafficking disguised as family donation.

When documentary evidence (birth certificates, Aadhaar, family photographs, etc.) isn’t enough to conclusively establish the relationship, the law requires DNA-based verification. Depending on the claimed relationship, this can involve autosomal STR profiling (for parent-child or sibling pairs), mitochondrial DNA analysis (for maternal-line relationships), or Y-STR analysis (for paternal-line, male relationships). These methods can support or refute a claimed relationship with a very high degree of confidence — protecting genuine donor families from delay, and protecting the system from abuse.

Form 5: Documentation That Supports the Process

Form 5 is the official certificate under the THOTA Rules in which a laboratory formally reports the outcome of this DNA/HLA-based relationship testing to the hospital’s Authorization Committee. Without a valid Form 5 report an Authorization Committee cannot approve a “near relative” living donor transplant if documentary evidence alone was inconclusive. In other words, Form 5 is often the single piece of paper standing between a family and a life-saving surgery date.

Our laboratory issues Form 5 certificates that hospitals and Authorization Committees across India recognize and rely on — with clear reporting timelines, chain-of-custody sample handling, and result explanations that families can actually understand at what is already a stressful time.

Single Antigen Bead assay

The Single Antigen Bead (SAB) assay is a Luminex-based method used to detect and characterize antibodies directed against individual HLA antigens.

SAB results can help define the recipient’s antibody profile, identify unacceptable antigens, and support a more informed donor evaluation.

Donor-Specific Antibodies: Luminex-based testing

Donor-specific antibodies (DSA) are recipient antibodies that recognize HLA antigens expressed by a particular donor. Luminex-based testing can help identify and characterize these antibodies.

DSA assessment can add an important layer to donor selection by helping the transplant team understand potential antibody-mediated immunological risk. Interpretation should consider clinical context, assay characteristics, antibody strength, complement-binding information when available, and laboratory thresholds.

Legal clearance and a good HLA match aren’t the whole picture — the recipient’s immune system may already carry antibodies against the donor’s specific HLA markers, raised by a prior pregnancy, transfusion, or earlier transplant. This is where Single Antigen Bead (SAB) assay and Luminex-based Donor-Specific Antibody (DSA) testing come in. By screening the recipient’s serum against a panel of individual HLA antigens, this testing detects pre-formed, donor-specific antibodies that could trigger antibody-mediated rejection — often before a conventional crossmatch would reveal a problem.

For transplant teams, this means donor selection isn’t just a legal and genetic question but an immunological risk assessment. Our lab offers Luminex-based SAB/DSA testing alongside HLA typing, so clinicians get a fuller risk picture before finalising a donor.

Putting the Tests Together: Donor Selection Scenario

STEP 1 — Clinical and ABO assessment
Confirm the clinical suitability of the donor and recipient, including ABO compatibility as applicable.

STEP 2 — HLA typing
Establish the donor and recipient HLA profiles.

STEP 3 — Kinship analysis
Where required, assess the claimed biological relationship using HLA-based analysis.

STEP 4 — Antibody profiling
Use SAB testing to define the recipient’s HLA antibody profile.

STEP 5 — DSA assessment
Compare the recipient antibody profile with the donor HLA type to identify donor-specific reactivity.

STEP 6 — Integrated interpretation
Combine laboratory findings with clinical history and transplant-team assessment to guide donor selection and risk management.

Illustrative Donor-Selection Scenario

Recipient: Sensitized transplant candidate.
Donor A: Good clinical fit, but antibody testing identifies relevant donor-specific reactivity.

Donor B: Suitable clinical profile with no significant DSA identified under the laboratory’s validated interpretation framework.

How the laboratory adds value:

• HLA typing establishes the genetic compatibility framework.
• SAB testing defines the recipient antibody landscape.
• DSA analysis links antibody findings to the specific donor.
• Kinship analysis can support relationship verification when required.
• Documentation and reporting support transparent multidisciplinary review.

This example is educational. It does not replace transplant-team judgment or institutional protocols.

Why Partner With Our Laboratory?

• Integrated HLA and antibody testing workflow.
• Luminex-based immunological assessment.
• Structured reporting for transplant teams.
• Support for complex donor–recipient evaluations.
• Emphasis on quality, traceability, and clinically relevant interpretation.

Our goal is simple: Help transplant teams make better-informed donor selection decisions with reliable immunogenetic evidence.

In Conclusion

Let us pledge to focus on better donor selection and smarter and safer transplantation

From HLA typing and kinship analysis to SAB/DSA screening and Form 5 documentation, accurate laboratory testing can support informed donor selection and transplant decision-making.

Need HLA typing, kinship/DNA analysis, SAB/DSA screening, or a Form 5 certificate for an upcoming transplant? Contact our customer support/technical support desk to know the sample requirements and turnaround time.

Because every transplant decision deserves the right science behind it.